Primo Nutraceuticals (Primo Nutraceuticals) EV-to-EBITDA : 0.00 (As of Jun. 17, 2024)

Primo Nutraceuticals EV-to-EBITDA Chart

Primo Nutraceuticals Quarterly Data
	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20
EV-to-EBITDA	Get a 7-Day Free Trial											-4.31	-3.92	-2.09	-2.38	-

Competitive Comparison of Primo Nutraceuticals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Primo Nutraceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Primo Nutraceuticals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Primo Nutraceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Primo Nutraceuticals's EV-to-EBITDA falls into.

Primo Nutraceuticals EV-to-EBITDA Calculation

Primo Nutraceuticals's EV-to-EBITDA for today is calculated as:

Primo Nutraceuticals's current Enterprise Value is $0.00 Mil.
Primo Nutraceuticals's EBITDA for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Primo Nutraceuticals  (OTCPK:BUGVF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Primo Nutraceuticals's PE Ratio for today is calculated as:

Primo Nutraceuticals's share price for today is $1.0E-6.
Primo Nutraceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.608.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Primo Nutraceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Primo Nutraceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Primo Nutraceuticals (Primo Nutraceuticals) Business Description